Toxoplasma IVDs

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Disponible desde:

Roche Diagnostics Australia Pty Limited

clase:

Class 3

Fabricado por:

Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany

Área terapéutica:

CT820 - Toxoplasma IVDs

indicaciones terapéuticas:

Immunoassays for the in vitro qualitative determination of IgG antibodies, the qualitative determination of the avidity of IgG antibodies and the qualitative determination of IgM antibodies to Toxoplasma gondii, including their respective control materials in human serum and plasma

Estado de Autorización:

A

Fecha de autorización:

2013-03-15